Member Info for Doc83

Let’s hope so. Yesterday has got to be a strong contender for the quietest day on this board for years. Calm before the storm?

xviolet, I am a sad individual and just dug it out for you. Numis based their estimations on the cost being £2000-3000.

xviolet - I’d have to dig out the old Numis research note, but I think their estimates were based on SNG charging £2k per course. Will have to double check, though.

I think (again) that it was discussed at the AGM briefly and seem to recall RM just saying it would represent good value. I suppose we all know that time in intensive care costs a hell of a lot of money, so £2k or thereabouts to keep someone out of it would be very worthwhile.

I'm also an anti vaxxer :D

There’s a great beer festival in Peterborough in a couple of weeks. A great way to lose a few days and help August go a bit quicker ;)

I think a few of us need a good drink!

The wheels really have come off this board the last few days/weeks!

“This is a dead stock.”

That’s a fairly concrete statement. Not “might be” a dead stock. It is.

So why not sell your shares before you lose £125k?

If we get to the end of September with no news then I might start to get a little twitchy.

???

I’m fairly sure that when Synairgen is bought out by AstraZeneca for £50 per share and we all have our celebration party at Big Johnny’s, that Ghia and Manifesto will end up getting it on… ;)

Woodstock - I don’t see an 80% drop. Or even a 50% drop.

Markets are driven by sentiment in the short term and there’s a lot of negative sentiment around right now. But over the longer term it is driven my fundamentals, the most important of which, I would argue, is what profits does a company(s) actually make.
We saw earnings growth in the US of around 7.5% in Q1 this year and with about half of companies having reported their Q2 numbers it is currently at 5%. More earnings growth is forecast going forward.
At some point, investors will get bored of the noise and actually look at the fundamentals, realising they can buy companies that are more profitable than a year earlier but that are 30-40% cheaper… bargain.

Equities offer decent protection against inflation because they can pass on input cost increases to the consumer (even McDonald’s has put the price of a burger up 20p for the first time in 14 years!) but history shows us that it can take a little time to feed through to the share prices.
I wouldn’t be surprised to see two consecutive 20%+ years on major markets, maybe more.

SSH was super excited when questioned about LC. I recall saying how he nearly jumped out of his chair. That wasn’t an exaggeration.

Think Back To The Future 1 where Marty is dying and then his mum and dad kiss on the dance floor and he jumps back to life. That was similar to SSH :D

All that being said, I think Ghia is right that we’ve probably seen some very encouraging signals but it will need some serious trialling to prove it beyond doubt.

Woodstock - the SP is, as it always has been, based on hope value. This could easily go to multiple billions in market cap terms if successful, or think in terms of odds, maybe 100/1 odds. So yes, it’s a long shot and is priced accordingly. I happen to think it’s better than 100/1 odds, though. Or even 20/1 odds. Hence me holding my shares.

Manifesto - Summer technically goes to 23rd September. Let's hope we hear something before then, however, I am much more calmer these days on the SNG timescales... for the sake of my sanity I have to be!

Manifesto - I think the "expected Summer" timeframe was a guess from them. From the AGM, I do not recall them saying they had been given any firm timescales from the US for when they might get the results.

Lol, Woody - you're such a wind up merchant! ;)

“Is it just my perception, or is the company "on hold" pending someone contacting them regarding the next steps?”

Palladin - that is absolutely correct. We are waiting for the US to give us the phase 2 ACTIV data and also whether or not we will be on an ACTIV phase 3 trial (unlikely) or an equivalent newly designed trial (more likely, I hope)

In addition, they are looking to get on a paid for platform trial. Synairgen are clearly good to go but are obviously waiting to be enrolled on one.

£5 would certainly put me close to retirement territory, about 20yrs ahead of schedule after averaging down considerably.

But I think we’re a way off from that yet.

Even though I have averaged down, in my mind and for my sanity, I have written off all of my investment in Synairgen. If it comes off, great. If it doesn’t, I won’t be as disappointed as I was on 21/2/22.

“It’s a peer review, Jim, but not as we know it”!

Sid1222 - There was a subsequent RNS that quoted “summer”. But the reality is that they are guessing and don’t know when they’ll get it.